Biogen scraps Alzheimer drug trials, wiping $17 billion off its market value
(Reuters) – Biogen and partner Eisai Co Ltd are ending two late-stage trials for the experimental Alzheimer’s drug aducanumab, in a setback to efforts to Read More
Many recovering from addiction have chronic health problems, diminished quality of life
Alcohol and other substance-use problems take enormous psychological and societal tolls on millions of Americans. Now a study from the Massachusetts General Hospital (MGH) Recovery Read More
Biogen scraps Alzheimer drug trials, shares slump by a quarter
TOKYO/BENGALURU (Reuters) – Biogen and partner Eisai Co Ltd are ending two late-stage trials testing the experimental Alzheimer’s drug aducanumab, marking the latest setback for Read More
Evidence for a Human Geomagnetic Sense
Scientists develop a robust experiment that shows human brain waves respond to changes in Earth-strength magnetic fields. Many humans are able to unconsciously detect changes Read More
Biogen scraps Alzheimer’s trial, shares skid
FILE PHOTO: The logo of Eisai Co Ltd is displayed at the company headquarters in Tokyo, Japan, March 8, 2018. REUTERS/Issei Kato (Reuters) – Biogen Read More
Kentucky governor says he intentionally exposed his children to chickenpox
Bruce Schreiner, The Associated PressPublished Thursday, March 21, 2019 7:34AM EDT FRANKFORT, Ky. — Kentucky Gov. Matt Bevin said in a radio interview that he Read More
Biogen, Eisai scrap Alzheimer drug trials
FILE PHOTO: The logo of Eisai Co Ltd is displayed at the company headquarters in Tokyo, Japan, March 8, 2018. REUTERS/Issei Kato (Reuters) – Biogen Read More
CBD May Possibly Interfere With Your Daily Medication
The interest in cannabidiol (aka CBD) ― a nonpsychoactive chemical found in marijuana and hemp plants ― is only growing. It has made its way Read More
Roche sues U.S. executives in fight over diabetes test strips
FILE PHOTO: Roche tablets are seen in front of a Roche logo in this photo illustration shot January 22, 2016. REUTERS/Dado Ruvic/File Photo ZURICH (Reuters) Read More
There’s no easy answer to the ‘one issue per visit’ problem
It’s difficult to find any statistics on it, but Canadians have likely encountered the “one issue per visit” rule in a doctor’s office or know of Read More